Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: CYBERKEN who wrote (10681)	11/3/1997 2:58:00 PM
From: Andrew H	Respond to of 32384

>>I like the ARRS SQNA merger. Out of both right now, but I may buy the resulting co later on.<< I like the merger also. I already own a bit of SQNA, so I will hold for now. Too bad ARRS took a hit. Truthfully, ARRS looks pretty cheap here. I think the merger will be good for the industry. Rather than each getting bought out by a larger pharm, the merger shows the industry is maturing. This newco will have substantially more prospects the either one alone. I haven't counted up the number of partners it will have with various large pharms, but they are many.